ACAN Fundamental Analysis - ACANTHE DEVELOPPEMENT SA

Fundamental Rating

ACAN gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 42 industry peers in the Diversified REITs industry. ACAN scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. ACAN is valued expensive and it does not seem to be growing.

Quickly go to:

1. Profitability

1.1 Basic Checks

ACAN had negative earnings in the past year.

ACAN had a negative operating cash flow in the past year.

The reported net income has been mixed in the past 5 years: ACAN reported negative net income in multiple years.

ACAN had a positive operating cash flow in 4 of the past 5 years.

1.2 Ratios

ACAN has a Return On Assets of -1.57%. This is in the lower half of the industry: ACAN underperforms 76.19% of its industry peers.

Looking at the Return On Equity, with a value of -1.87%, ACAN is doing worse than 76.19% of the companies in the same industry.

Looking at the Return On Invested Capital, with a value of 0.35%, ACAN is doing worse than 88.10% of the companies in the same industry.

		Industry Rank	Sector Rank
ROA	-1.57%
ROE	-1.87%
ROIC	0.35%

ROA(3y)-2.84%

ROA(5y)-1.12%

ROE(3y)-3.39%

ROE(5y)-1.48%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

The Operating Margin of ACAN (16.00%) is worse than 83.33% of its industry peers.

In the last couple of years the Operating Margin of ACAN has grown nicely.

ACAN has a Gross Margin of 73.58%. This is comparable to the rest of the industry: ACAN outperforms 52.38% of its industry peers.

ACAN's Gross Margin has been stable in the last couple of years.

		Industry Rank	Sector Rank
OM	16%
PM (TTM)	N/A
GM	73.58%

OM growth 3YN/A

OM growth 5Y106.65%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.26%

GM growth 5Y-1.25%

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ACAN has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.

The number of shares outstanding for ACAN has been increased compared to 1 year ago.

ACAN has more shares outstanding than it did 5 years ago.

Compared to 1 year ago, ACAN has a worse debt to assets ratio.

2.2 Solvency

ACAN has an Altman-Z score of 2.17. This is not the best score and indicates that ACAN is in the grey zone with still only limited risk for bankruptcy at the moment.

The Altman-Z score of ACAN (2.17) is better than 100.00% of its industry peers.

A Debt/Equity ratio of 0.01 indicates that ACAN is not too dependend on debt financing.

Looking at the Debt to Equity ratio, with a value of 0.01, ACAN belongs to the top of the industry, outperforming 97.62% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	N/A
Altman-Z	2.17

ROIC/WACC0.04

WACC7.93%

2.3 Liquidity

ACAN has a Current Ratio of 2.06. This indicates that ACAN is financially healthy and has no problem in meeting its short term obligations.

With an excellent Current ratio value of 2.06, ACAN belongs to the best of the industry, outperforming 95.24% of the companies in the same industry.

ACAN has a Quick Ratio of 2.06. This indicates that ACAN is financially healthy and has no problem in meeting its short term obligations.

ACAN's Quick ratio of 2.06 is amongst the best of the industry. ACAN outperforms 95.24% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	2.06
Quick Ratio	2.06

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

ACAN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 85.11%, which is quite impressive.

ACAN shows a decrease in Revenue. In the last year, the revenue decreased by -5.50%.

ACAN shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -6.49% yearly.

EPS 1Y (TTM)85.11%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%83.87%

Revenue 1Y (TTM)-5.5%

Revenue growth 3Y0.44%

Revenue growth 5Y-6.49%

Sales Q2Q%-9.58%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.

No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ACAN. In the last year negative earnings were reported.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2YN/A

EPS Next 3YN/A

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

No dividends for ACAN!.

		Industry Rank	Sector Rank
Dividend Yield	N/A

More info and screens

Find the best dividend stocks

Show peers with best dividend

ACANTHE DEVELOPPEMENT SA

EPA:ACAN (10/10/2025, 7:00:00 PM)

0.233

-0.02 (-7.54%)

Chartmill FA Rating

GICS SectorReal Estate

GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)

GICS IndustryDiversified REITs

Earnings (Last)09-26 2025-09-26

Earnings (Next)N/A N/A

Inst OwnersN/A

Inst Owner ChangeN/A

Ins Owners55.99%

Ins Owner ChangeN/A

Market Cap38.53M

AnalystsN/A

Price TargetN/A

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	N/A

Yearly Dividend0.02

Dividend Growth(5Y)-46.74%

DP-134.16%

Div Incr Years1

Div Non Decr Years1

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)N/A

PT rev (3m)N/A

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)N/A

EPS NY rev (3m)N/A

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)N/A

Revenue NY rev (3m)N/A

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	10.32
P/FCF	N/A
P/OCF	N/A
P/B	0.34
P/tB	0.34
EV/EBITDA	N/A

EPS(TTM)-0.01

EYN/A

EPS(NY)N/A

Fwd EYN/A

FCF(TTM)-0.04

FCFYN/A

OCF(TTM)-0.04

OCFYN/A

SpS0.02

BVpS0.68

TBVpS0.68

PEG (NY)N/A

PEG (5Y)N/A

Profitability

		Industry Rank	Sector Rank
ROA	-1.57%
ROE	-1.87%
ROCE	0.48%
ROIC	0.35%
ROICexc	0.35%
ROICexgc	0.35%
OM	16%
PM (TTM)	N/A
GM	73.58%
FCFM	N/A

ROA(3y)-2.84%

ROA(5y)-1.12%

ROE(3y)-3.39%

ROE(5y)-1.48%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexcg growth 3YN/A

ROICexcg growth 5Y110.88%

ROICexc growth 3YN/A

ROICexc growth 5Y110.88%

OM growth 3YN/A

OM growth 5Y106.65%

PM growth 3YN/A

PM growth 5YN/A

GM growth 3Y-0.26%

GM growth 5Y-1.25%

F-Score4

Asset Turnover0.03

Health

		Industry Rank	Sector Rank
Debt/Equity	0.01
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	N/A
Cap/Sales	1.1%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	2.06
Quick Ratio	2.06
Altman-Z	2.17

F-Score4

WACC7.93%

ROIC/WACC0.04

Cap/Depr(3y)N/A

Cap/Depr(5y)N/A

Cap/Sales(3y)3.26%

Cap/Sales(5y)6.74%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)85.11%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%83.87%

EPS Next YN/A

EPS Next 2YN/A

EPS Next 3YN/A

EPS Next 5YN/A

Revenue 1Y (TTM)-5.5%

Revenue growth 3Y0.44%

Revenue growth 5Y-6.49%

Sales Q2Q%-9.58%

Revenue Next YearN/A

Revenue Next 2YN/A

Revenue Next 3YN/A

Revenue Next 5YN/A

EBIT growth 1Y107.24%

EBIT growth 3YN/A

EBIT growth 5Y93.23%

EBIT Next YearN/A

EBIT Next 3YN/A

EBIT Next 5YN/A

FCF growth 1Y-178.62%

FCF growth 3YN/A

FCF growth 5Y20.72%

OCF growth 1Y-177.13%

OCF growth 3YN/A

OCF growth 5Y-16.48%

ACANTHE DEVELOPPEMENT SA (ACAN.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens